Ten EMA initiatives will strengthen clinical research in Europe

The framework conditions for clinical research in Europe have proved challenging and difficult, the EMA says. With ten new initiatives, the European health authority wants to change how trials are designed, initiated and conducted. Industry association Lif welcomes the changes.
With ten new initiatives, the European health authority wants to strenghten clinical research in Europe | Photo: Bioneer / PR
With ten new initiatives, the European health authority wants to strenghten clinical research in Europe | Photo: Bioneer / PR
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen

Clinical trials are a necessity for the development of drugs, medical equipment, new treatments and the life science industry at large.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading